Karakus KE, Chesshir L, Walker S, Baschal EE, et al. Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes. Diabetologia 2026 Jan 15. doi: 10.1007/s00125-025-06646.
PMID: 41535597